{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:38:29Z","timestamp":1779176309011,"version":"3.51.4"},"reference-count":68,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,2,10]]},"DOI":"10.1253\/circrep.cr-24-0161","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T22:10:48Z","timestamp":1738102248000},"page":"59-65","source":"Crossref","is-referenced-by-count":2,"title":["Role of Cardio-Oncology Rehabilitation in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell (CAR-T) Therapy"],"prefix":"10.1253","volume":"7","author":[{"given":"Shohei","family":"Moriyama","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Awamura","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinari","family":"Hieda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Fukata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). <i>Eur Heart J<\/i> 2022; 43: 4229\u20134361.","DOI":"10.1093\/eurheartj\/ehac244"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bojan A, Torok-Vistai T, Parvu A. Assessment and management of cardiotoxicity in hematologic malignancies. <i>Dis Markers<\/i> 2021; 2021: 1\u201310.","DOI":"10.1155\/2021\/6616265"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Alvi RM, Frigault MJ, Fradley MG, Jain MD, Mahmood SS, Awadalla M, et al. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T). <i>J Am Coll Cardiol<\/i> 2019; 74: 3099\u20133108.","DOI":"10.1016\/j.jacc.2019.10.038"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Van Haren IEPM, Timmerman H, Potting CM, Blijlevens NMA, Staal JB, Nijhuis-Van Der Sanden MWG. Physical exercise for patients undergoing hematopoietic stem cell transplantation: Systematic review and meta-analyses of randomized controlled trials. <i>Phys Ther<\/i> 2013; 93: 514\u2013528.","DOI":"10.2522\/ptj.20120181"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Persoon S, Kersten MJ, Van Der Weiden K, Buffart LM, Nollet F, Brug J, et al. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis. <i>Cancer Treat Rev<\/i> 2013; 39: 682\u2013690.","DOI":"10.1016\/j.ctrv.2013.01.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A Scientific Statement From the American Heart Association. <i>Circulation<\/i> 2019; 139: e997\u2013e1012.","DOI":"10.1161\/CIR.0000000000000679"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. <i>J Clin Oncol<\/i> 2009; 27: 4605\u20134612.","DOI":"10.1200\/JCO.2008.20.0634"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers ME, Martin PJ, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. <i>Ann Intern Med<\/i> 2011; 155: 21\u201332.","DOI":"10.7326\/0003-4819-155-1-201107050-00004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Armenian SH, Sun CL, Shannon T, Mills G, Francisco L, Venkataraman K, et al. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. <i>Blood<\/i> 2011; 118: 6023\u20136029.","DOI":"10.1182\/blood-2011-06-358226"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cazin B, Gorin NC, Laporte JP, Gallet B, Douay L, Lopez M, et al. Cardiac complications after bone marrow transplantation: A report on a series of 63 consecutive transplantations. <i>Cancer<\/i> 1986; 57: 2061\u20132069.","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hayek SS, Zaha VG, Bogle C, Deswal A, Langston A, Rotz S, et al. Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from pretransplantation to survivorship: A Scientific Statement From the American Heart Association. <i>Circulation<\/i> 2024; 149: e1113\u2013e1127.","DOI":"10.1161\/CIR.0000000000001220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saad A, Loren A, Bola\u00f1os-Meade J, Chen G, Couriel D, Di Stasi A, et al. NCCN Guidelines<sup>\u00ae<\/sup> Insights: Hematopoietic Cell Transplantation, Version 3.2022. <i>J Natl Compr Canc Netw<\/i> 2023; 21: 108\u2013115.","DOI":"10.6004\/jnccn.2023.0007"},{"key":"13","unstructured":"13. Dogan A, Dogdu O, Ozdogru I, Yarlioglues M, Kalay N, Inanc MT, et al. Cardiac effects of chronic graft-versus-host disease after stem cell transplantation. <i>Tex Heart Inst J<\/i> 2013; 40: 428\u2013434."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Moriyama S, Fukata M, Hieda M, Yokoyama T, Yoshimoto G, Kusaba H, et al. Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation. <i>Open Heart<\/i> 2022; 9: e002007.","DOI":"10.1136\/openhrt-2022-002007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, et al. Dilated cardiomyopathy. <i>Nat Rev Dis Primers<\/i> 2019; 5: 32.","DOI":"10.1038\/s41572-019-0084-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Armenian SH, Sun CL, Vase T, Ness KK, Blum E, Francisco L, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: Role in development of subsequent cardiovascular disease. <i>Blood<\/i> 2012; 120: 4505\u20134512.","DOI":"10.1182\/blood-2012-06-437178"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chow EJ, Baker KS, Lee SJ, Flowers ME, Cushing-Haugen KL, Inamoto Y, et al. Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation. <i>J Clin Oncol<\/i> 2014; 32: 191\u2013198.","DOI":"10.1200\/JCO.2013.52.6582"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Atkison P, Joubert G, Barron A, Grant D, Wall W, Rosenberg H, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. <i>Lancet<\/i> 1995; 345: 894\u2013896.","DOI":"10.1016\/S0140-6736(95)90011-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hertenstein B, Stefanic M, Schmeiser T, Scholz M, Goller V, Clausen M, et al. Cardiac toxicity of bone marrow transplantation: Predictive value of cardiologic evaluation before transplant. <i>J Clin Oncol<\/i> 1994; 12: 998\u20131004.","DOI":"10.1200\/JCO.1994.12.5.998"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Barrett DM, Grupp SA, June CH. Chimeric antigen receptor and TCR-modified T cells enter Main Street and Wall Street. <i>J Immunol<\/i> 2015; 195: 755\u2013761.","DOI":"10.4049\/jimmunol.1500751"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Koeckerling D, Reddy RK, Barker J, Eichhorn C, Divall P, Howard JP, et al. Cardiovascular events after chimeric antigen receptor T-cell therapy for advanced hematologic malignant neoplasms. <i>JAMA Netw Open<\/i> 2024; 7: e2437222.","DOI":"10.1001\/jamanetworkopen.2024.37222"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Fischer JW, Bhattarai N. CAR-T cell therapy: Mechanism, management, and mitigation of inflammatory toxicities. <i>Front Immunol<\/i> 2021; 12: 693016.","DOI":"10.3389\/fimmu.2021.693016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wei J, Liu Y, Wang C, Zhang Y, Tong C, Dai G, et al. The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma. <i>Signal Transduct Target Ther<\/i> 2020; 5: 134.","DOI":"10.1038\/s41392-020-00256-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. <i>Lancet<\/i> 2004; 363: 203\u2013209.","DOI":"10.1016\/S0140-6736(03)15326-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement c3. <i>Circulation<\/i> 2003; 107: 320\u2013325.","DOI":"10.1161\/01.CIR.0000043802.38699.66"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. <i>Nat Rev Cardiol<\/i> 2021; 18: 424\u2013434.","DOI":"10.1038\/s41569-020-00492-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lefebvre B, Kang Y, Vakilpour A, Onoue T, Frey NV, Brahmbhatt P, et al. Incidence of MACE in patients treated with CAR-T cell therapy: A prospective study. <i>JACC CardioOncol<\/i> 2023; 5: 747\u2013754.","DOI":"10.1016\/j.jaccao.2023.07.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hu JR, Patel A, Huang S, Su YR, Dahlman KB, Tomasek K, et al. High sensitivity troponin T and NT-proBNP in patients receiving chimeric antigen receptor (CAR) T-cell therapy. <i>Clin Hematol Int<\/i> 2021; 3: 96.","DOI":"10.2991\/chi.k.210718.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ganatra S, Redd R, Hayek SS, Parikh R, Azam T, Yanik GA, et al. Chimeric antigen receptor T-cell therapy-associated cardiomyopathy in patients with refractory or relapsed non-Hodgkin lymphoma. <i>Circulation<\/i> 2020; 142: 1687\u20131690.","DOI":"10.1161\/CIRCULATIONAHA.120.048100"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Salem JE, Ederhy S, Lebrun-Vignes B, Moslehi JJ. Cardiac events associated with chimeric antigen receptor T-cells (CAR-T). <i>J Am Coll Cardiol<\/i> 2020; 75: 2521\u20132523.","DOI":"10.1016\/j.jacc.2020.02.070"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Moriyama S, Fukata M, Yokoyama T, Ueno S, Nunomura T, Mori Y, et al. Case report: Cardiac tamponade in association with cytokine release syndrome following CAR-T cell therapy. <i>Front Cardiovasc Med<\/i> 2022; 9: 848091.","DOI":"10.3389\/fcvm.2022.848091"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hacker ED, Collins E, Park C, Peters T, Patel P, Rondelli D. Strength training to enhance early recovery after hematopoietic stem cell transplantation. <i>Biol Blood Marrow Transplant<\/i> 2017; 23: 659\u2013669.","DOI":"10.1016\/j.bbmt.2016.12.637"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takekiyo T, Dozono K, Mitsuishi T, Murayama Y, Maeda A, Nakano N, et al. Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation. <i>Support Care Cancer<\/i> 2015; 23: 985\u2013992.","DOI":"10.1007\/s00520-014-2425-7"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. <i>N Engl J Med<\/i> 2017; 377: 2531\u20132544.","DOI":"10.1056\/NEJMoa1707447"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hoogland AI, Jayani RV, Collier A, Irizarry-Arroyo N, Rodriguez Y, Jain MD, et al. Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel. <i>Cancer Med<\/i> 2021; 10: 1936\u20131943.","DOI":"10.1002\/cam4.3664"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sidana S, Thanarajasingam G, Griffin J, Thompson CA, Burtis M, Warsame R, et al. Patient experience of chimeric antigen receptor (CAR)-T cell therapy vs. stem cell transplant: Longitudinal patient reported adverse events, cognition and quality of life. <i>Blood<\/i> 2019; 134: 794\u2013794.","DOI":"10.1182\/blood-2019-121715"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Bodine SC. Disuse-induced muscle wasting. <i>Int J Biochem Cell Biol<\/i> 2013; 45: 2200\u20132208.","DOI":"10.1016\/j.biocel.2013.06.011"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Phillips SM, Glover EI, Rennie MJ. Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. <i>J Appl Physiol (1985)<\/i> 2009; 107: 645\u2013654.","DOI":"10.1152\/japplphysiol.00452.2009"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Peterson JM, Bakkar N, Guttridge DC. NF-kappaB signaling in skeletal muscle health and disease. <i>Curr Top Dev Biol<\/i> 2011; 96: 85\u2013119.","DOI":"10.1016\/B978-0-12-385940-2.00004-8"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda SI, et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. <i>Cell Metab<\/i> 2011; 13: 170\u2013182.","DOI":"10.1016\/j.cmet.2011.01.001"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Haran M, Schattner A, Kozak N, Mate A, Berrebi A, Shvidel L. Acute steroid myopathy: A highly overlooked entity. <i>Q J Med<\/i> 2018; 111: 307\u2013311.","DOI":"10.1093\/qjmed\/hcy031"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Morishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K, et al. Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. <i>Support Care Cancer<\/i> 2013; 21: 2161\u20132169.","DOI":"10.1007\/s00520-013-1778-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Mosher CE, Redd WH, Rini CM, Burkhalter JE, Duhamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: A review of the literature. <i>Psychooncology<\/i> 2009; 18: 113\u2013127.","DOI":"10.1002\/pon.1399"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Jones LW, Devlin SM, Maloy MA, Wood WA, Tuohy S, Espiritu N, et al. Prognostic importance of pretransplant functional capacity after allogeneic hematopoietic cell transplantation. <i>Oncologist<\/i> 2015; 20: 1290\u20131297.","DOI":"10.1634\/theoncologist.2015-0200"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: Evidence for a phenotype. <i>J Gerontol A Biol Sci Med Sci<\/i> 2001; 56: M146\u2013M156.","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Chi AK, Soubani AO, White AC, Miller KB. An update on pulmonary complications of hematopoietic stem cell transplantation. <i>Chest<\/i> 2013; 144: 1913\u20131922.","DOI":"10.1378\/chest.12-1708"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Haider S, Durairajan N, Soubani AO. Noninfectious pulmonary complications of haematopoietic stem cell transplantation. <i>Eur Resp Rev<\/i> 2020; 29: 190119.","DOI":"10.1183\/16000617.0119-2019"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Sun Z, Xie C, Liu H, Yuan X. CD19 CAR-T cell therapy induced immunotherapy associated interstitial pneumonitis: A case report. <i>Front Immunol<\/i> 2022; 13: 778192.","DOI":"10.3389\/fimmu.2022.778192"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galv\u00e3o DA, Pinto BM, et al. American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors. <i>Med Sci Sports Exerc<\/i> 2010; 42: 1409\u20131426.","DOI":"10.1249\/MSS.0b013e3181e0c112"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. <i>CA Cancer J Clin<\/i> 2012; 62: 242\u2013274.","DOI":"10.3322\/caac.21142"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L. Strength training following hematopoietic stem cell transplantation. <i>Cancer Nurs<\/i> 2011; 34: 238\u2013249.","DOI":"10.1097\/NCC.0b013e3181fb3686"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Obaisi O, Fontillas RC, Patel K, Ngo-Huang A. rehabilitation needs for patients undergoing CAR T-cell therapy. <i>Curr Oncol Rep<\/i> 2022; 24: 741\u2013749.","DOI":"10.1007\/s11912-022-01240-0"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, et al. Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. <i>Ann Oncol<\/i> 2014; 25: 493\u2013499.","DOI":"10.1093\/annonc\/mdt568"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. <i>J Clin Oncol<\/i> 2017; 35: 893\u2013911.","DOI":"10.1200\/JCO.2016.70.5400"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Grandin EW, Ky B, Cornell RF, Carver J, Lenihan DJ. Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myeloma. <i>J Card Fail<\/i> 2015; 21: 138\u2013144.","DOI":"10.1016\/j.cardfail.2014.11.008"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise therapy and cardiovascular toxicity in cancer. <i>Circulation<\/i> 2018; 137: 1176\u20131191.","DOI":"10.1161\/CIRCULATIONAHA.117.024671"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: A systematic review and meta-analysis. <i>J Clin Oncol<\/i> 2018; 36: 2297\u20132305.","DOI":"10.1200\/JCO.2017.77.5809"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Zhou Y, Zhu J, Gu Z, Yin X. Efficacy of exercise interventions in patients with acute leukemia: A meta-analysis. <i>PLoS One<\/i> 2016; 11: e0159966.","DOI":"10.1371\/journal.pone.0159966"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Carlson LE, Smith D, Russell J, Fibich C, Whittaker T. Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: A pilot study. <i>Bone Marrow Transplant<\/i> 2006; 37: 945\u2013954.","DOI":"10.1038\/sj.bmt.1705343"},{"key":"60","unstructured":"60. Dimeo F, Bertz H, Finke J, Fetscher S, Mertelsmann R, Keul J. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. <i>Bone Marrow Transplant<\/i> 1996; 18: 1157\u20131160."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Wilson RW, Jacobsen PB, Fields KK. Pilot study of a home-based aerobic exercise program for sedentary cancer survivors treated with hematopoietic stem cell transplantation. <i>Bone Marrow Transplant<\/i> 2005; 35: 721\u2013727.","DOI":"10.1038\/sj.bmt.1704815"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Makita S, Yasu T, Akashi YJ, Adachi H, Izawa H, Ishihara S, et al. JCS\/JACR 2021 Guideline on rehabilitation in patients with cardiovascular disease. <i>Circ J<\/i> 2022; 87: 155\u2013235.","DOI":"10.1253\/circj.CJ-22-0234"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Fu JB, Tennison JM, Rutzen-Lopez IM, Silver JK, Morishita S, Dibaj SS, et al. Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia. <i>Support Care Cancer<\/i> 2018; 26: 3135\u20133141.","DOI":"10.1007\/s00520-018-4160-y"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Stubblefield MD. Cancer rehabilitation: Principles and practice: Springer Publishing Company, 2018.","DOI":"10.1891\/9780826121646"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Martin-Salces M, de Paz R, Canales MA, Mesejo A, Hernandez-Navarro F. Nutritional recommendations in hematopoietic stem cell transplantation. <i>Nutrition<\/i> 2008; 24: 769\u2013775.","DOI":"10.1016\/j.nut.2008.02.021"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Fuji S, Kim SW, Fukuda T, Kamiya S, Kuwahara S, Takaue Y. Positive impact of maintaining minimal caloric intake above 1.0\u00d7basal energy expenditure on the nutritional status of patients undergoing allogeneic hematopoietic stem cell transplantation. <i>Am J Hematol<\/i> 2009; 84: 63\u201364.","DOI":"10.1002\/ajh.21307"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. <i>Clin Nutr<\/i> 2017; 36: 11\u201348.","DOI":"10.1016\/j.clnu.2016.07.015"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: A randomized, double-blind, controlled study. <i>Ann Intern Med<\/i> 1992; 116: 821\u2013828.","DOI":"10.7326\/0003-4819-116-10-821"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/2\/7_CR-24-0161\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T03:30:04Z","timestamp":1739590204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/2\/7_CR-24-0161\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-24-0161","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"article-number":"CR-24-0161"}}